Recent advances in bone tissue engineering scaffolds

Trends in Biotechnology

Volumn 30, Issue 10, 2012, Pages 546-554

  Bose, Susmita ^a   Roy, Mangal ^a   Bandyopadhyay, Amit ^a  

^a Washington State University   (United States)

Author keywords

Biomechanical properties; Biomolecule delivery; Bone scaffolds; In vitro and in vivo studies; Osteoinduction; Vascularization

Indexed keywords

BIOMECHANICAL PROPERTIES; BONE SCAFFOLDS; IN-VITRO; OSTEOINDUCTION; VASCULARIZATION;

BIOMATERIALS; BIOMECHANICS; BONE; GENES; RESTORATION; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; FIBROBLAST GROWTH FACTOR; TANTALUM; TISSUE SCAFFOLD; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; BONE TISSUE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICROTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

BIOTECHNOLOGY; BONE AND BONES; BONE REGENERATION; HUMANS; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84866415693     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.07.005     Document Type: Review

References (80)

1. Khan Y., et al. Tissue engineering of bone: material and matrix considerations. JBJS 2008, 90:36-42.
2. Cao H., Kuboyama N. A biodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering. Bone 2010, 46:386-395.
3. Cao X., Chen D. The BMP signaling and in vivo bone formation. Gene 2005, 357:1-8.
4. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 2012, 12:159-169.
5. Li J., et al. Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2. J. Orthop. Res. 2011, 29:1745-1752.
6. Rouwkema J., et al. Vascularization in tissue engineering. Trends Biotechnol. 2008, 26:434-441.
7. Bramfeldt H., et al. Scaffold vascularization: a challenge for three-dimensional tissue engineering. Curr. Med. Chem. 2010, 17:3944-3967.
8. Jain R.K., et al. Engineering vascularized tissue. Nat. Biotechnol. 2005, 23:821-823.
9. Malda J., et al. Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling. Biotechnol. Bioeng. 2004, 86:9-18.
10. Garcia P., et al. Temporal and spatial vascularization patterns of unions and nonunions: role of vascular endothelial growth factor and bone morphogenetic proteins. J. Bone Joint Surg. Am. 2012, 94:49-58.
11. Wernike E., et al. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur. Cell Mater. 2010, 19:30-40.
12. Clarkin C.E., et al. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J. Cell. Physiol. 2008, 214:537-544.
13. Li R., et al. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J. Orthop. Res. 2009, 27:8-14.
14. Olszta M.J., et al. Bone structure and formation: A new perspective. Mater. Sci. Eng. R: Rep. 2007, 58:77-116.
15. Bose S., et al. Processing of controlled porosity ceramic structures via fused deposition. Scripta Mater. 1999, 41:1009-1014.
16. Darsell J., et al. From CT scan to ceramic bone graft. J. Am. Ceram. Soc. 2003, 86:1076-1080.
17. Hutmacher D.W., et al. Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol. 2004, 22:354-362.
18. Fielding G.A., et al. Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds. Dent Mater. 2012, 28:113-122.
19. Tarafder, S. et al. Microwave-sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering. J. Tissue Eng. Regen. Med. doi:10.1002/term.555.
20. Balla V.K., et al. Porous tantalum structures for bone implants: Fabrication, mechanical and in vitro biological properties. Acta Biomater. 2010, 6:3349-3359.
21. Xue W., et al. Processing and biocompatibility evaluation of laser processed porous titanium. Acta Biomater. 2007, 3:1007-1018.
22. Rezwan K., et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006, 27:3413-3431.
23. Holzwarth J.M., Ma P.X. Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 2011, 32:9622-9629.
24. Luo C.J., et al. A novel method of selecting solvents for polymer electrospinning. Polymer 2010, 51:1654-1662.
25. Seyednejad H., et al. An electrospun degradable scaffold based on a novel hydrophilic polyester for tissue-engineering applications. Macromol. Biosci. 2011, 11:1684-1692.
26. Phipps M.C., et al. Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials 2012, 33:524-534.
27. Cicotte K.N., et al. Synthesis and electrospun fiber mats of low T(g) poly(propylene fumerate-co-propylene maleate). J. Appl. Polym. Sci. 2010, 117:1984-1991.
28. Karageorgiou V., Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005, 26:5474-5491.
29. Teixeira S., et al. In vivo evaluation of highly macroporous ceramic scaffolds for bone tissue engineering. J. Biomed. Mater. Res. 2010, 93A:567-575.
30. Woodard J.R., et al. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 2007, 28:45-54.
31. Banerjee S.S., et al. Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of β-TCP ceramics. Acta Biomater. 2010, 6:4167-4174.
32. Bose S., et al. Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped β-TCP. Bone 2011, 48:1282-1290.
33. Shie M.-Y., et al. The role of silicon in osteoblast-like cell proliferation and apoptosis. Acta Biomater. 2011, 7:2604-2614.
34. Jones J.R., et al. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials 2006, 27:964-973.
35. Miguel B.S., et al. Enhanced osteoblastic activity and bone regeneration using surface-modified porous bioactive glass scaffolds. J. Biomed. Mater. Res. Part A 2010, 94A:1023-1033.
36. Wu C., et al. Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials 2012, 33:2076-2085.
37. Lichte P., et al. Scaffolds for bone healing: concepts, materials and evidence. Injury 2011, 42:569-573.
38. Lee S.-H., Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv. Drug Deliv. Rev. 2007, 59:339-359.
39. Yan J., et al. Cross-linking characteristics and mechanical properties of an injectable biomaterial composed of polypropylene fumarate and polycaprolactone co-polymer. J. Biomater. Sci. Polym. Ed. 2011, 22:489-504.
40. Cheung H.-Y., et al. A critical review on polymer-based bio-engineered materials for scaffold development. Compos. Part B: Eng. 2007, 38:291-300.
41. Xue W., et al. Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. J. Biomed. Mater. Res. Part B: Appl. Biomater. 2009, 91B:831-838.
42. Laschke M.W., et al. In vitro and in vivo evaluation of a novel nanosize hydroxyapatite particles/poly(ester-urethane) composite scaffold for bone tissue engineering. Acta Biomater. 2010, 6:2020-2027.
43. Roohani-Esfahani S.-I., et al. The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites. Biomaterials 2010, 31:5498-5509.
44. Dabrowski B., et al. Highly porous titanium scaffolds for orthopaedic applications. J. Biomed. Mater. Res. Part B: Appl. Biomater. 2010, 95B:53-61.
45. Das K., et al. Surface modification of laser-processed porous titanium for load-bearing implants. Scripta Mater. 2008, 59:822-825.
46. Yun Y., et al. Revolutionizing biodegradable metals. Mater. Today 2009, 12:22-32.
47. Witte F., et al. Biodegradable magnesium scaffolds: Part II: Peri-implant bone remodeling. J. Biomed. Mater. Res. Part A 2007, 81A:757-765.
48. Papadimitropoulos A., et al. Kinetics of in vivo bone deposition by bone marrow stromal cells within a resorbable porous calcium phosphate scaffold: An X-ray computed microtomography study. Biotechnol. Bioeng. 2007, 98:271-281.
49. Eniwumide J.O., et al. Ectopic bone formation in bone marrow stem cell seeded calcium phosphate scaffolds as compared to autograft and (cell seeded) allograft. Eur. Cell Mater. 2007, 14:30-38. discussion 39.
50. Naito H., et al. The Effect of Mesenchymal Stem Cell Osteoblastic Differentiation on the Mechanical Properties of Engineered Bone-Like Tissue. Tissue Eng. Part A 2011, 17:2321-2329.
51. Thein-Han W., Xu H.H.K. Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering. Tissue Eng. Part A 2011, 17:2943-2954.
52. Koob S., et al. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng. Part A 2011, 17:311-321.
53. Kempen D.H.R., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30:2816-2825.
54. Patel Z.S., et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43:931-940.
55. Young S., et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng. Part A. 2009, 15:2347-2362.
56. Kang H., et al. Insulin-like growth factor 2 promotes osteogenic cell differentiation in the parthenogenetic murine embryonic stem cells. Tissue Eng. Part A 2012, 18:331-341.
57. Bose S., Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012, 8:1401-1421.
58. Verron E., et al. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discov. Today 2010, 15:547-552.
59. Kimelman-Bleich N., et al. Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol. Ther. 2010, 19:53-59.
60. Keeney M., et al. The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF165. Biomaterials 2010, 31:2893-2902.
61. Fischer J., et al. Future of local bone regeneration - protein versus gene therapy. J. Cranio-Maxillofacial Surg. 2011, 39:54-64.
62. Lan Levengood S.K., et al. The effect of BMP-2 on micro- and macroscale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity. Acta Biomater. 2010, 6:3283-3291.
63. Bessa P.C., et al. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J. Tissue Eng. Regen. Med. 2008, 2:81-96.
64. Patel Z.S., et al. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm. Res. 2008, 25:2370-2378.
65. Scaglione S., et al. Order versus disorder: in vivo bone formation within osteoconductive scaffolds. Sci. Rep. 2012, 2. Article no. 274.
66. Hench L.L. Bioceramics: from concept to clinic. J. Am. Ceram. Soc. 1991, 74:1487-1510.
67. Coleman J.E. Structure and mechanism of alkaline phosphatase. Annu. Rev. Biophys. Biomol. Struct. 1992, 21:441-483.
68. Chanda D., et al. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J. Cell. Biochem. 2010, 111:249-257.
69. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25:2896-2902.
70. Badylak S.F., et al. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 2009, 5:1-13.
71. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
72. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
73. Kachgal S., Putnam A. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis 2011, 14:47-59.
74. Lin G., et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res. 2007, 17:999-1007.
75. Buijs J.T., et al. The role of TGF-[beta] in bone metastasis: novel therapeutic perspectives. BoneKEy Rep. 2012, 1. Article no. 96.
76. Grellier M., et al. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J. Cell. Biochem. 2009, 106:390-398.
77. Nomi M., et al. Principals of neovascularization for tissue engineering. Mol. Aspects Med. 2002, 23:463-483.
78. Fu Q., et al. Three-dimensional visualization of bioactive glass-bone integration in a rabbit tibia model using synchrotron X-ray microcomputed tomography. Tissue Eng. Part A 2011, 17:3077-3084.
79. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
80. Murphy C.M., et al. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31:461-466.